Jasper Gerritsen
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Jasper Gerritsen sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Jasper Gerritsen: 4 sponsored US clinical trials, 4 recruiting.
Jasper Gerritsen sponsors 4 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting. The most-studied condition in this pipeline is Glioblastoma Multiforme, Adult, with 4 trials.
Upper-quartile sponsor footprint
Jasper Gerritsen sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
4 total, page 1 of 1
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
NCT06146738
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
NCT06283927
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
NCT06146725
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
NCT06118723
What is open in the Jasper Gerritsen pipeline
4 recruiting of 4 indexed (100% open).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Glioblastoma Multiforme, Adult (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Jasper Gerritsen: open-pipeline peers nationwide
Peers matched on 4 registered trials and 100% open enrollment, not the therapeutic-area sidebar.
Jasper Gerritsen sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 trials (± recruiting share)
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors near 100% open enrollment (± trial volume)
- AAVantgarde Bio Srl · 100% recruiting · 2 trials
- Acorn Biolabs · 100% recruiting · 3 trials
- Acrivon Therapeutics · 100% recruiting · 2 trials
- ADARx Pharmaceuticals · 100% recruiting · 4 trials
Related
What to do with this Jasper Gerritsen page
4 registered trials is a research-attention snapshot, not an endorsement of Jasper Gerritsen or any single study.
- 4 of Jasper Gerritsen's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Glioblastoma Multiforme, Adult is the condition Jasper Gerritsen studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Glioblastoma Multiforme, Adult trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Jasper Gerritsen pipeline card: 4 registered trials from official public datasets.Report a data error.